NASDAQ · STOCK
Merck & Co.
$123.48
52W $76.66 – $130.29
59/100
$308.90B
34.7
0.21
Price History (6M)
Executive Summary
7 analysts weighed in with 43% agreement on a bullish lean. Portfolio Manager: Portfolio position concentration is currently healthy. Risk Analyst: Bollinger bandwidth of 17.9% signals elevated volatility. Overall recommendation: WATCH.
Bull & Bear Case
Bull Case
- Daily trend: uptrend.
- Weekly trend: uptrend.
- Daily and weekly trends are both bullish — multi-timeframe alignment, highest confidence.
- Daily volatility (ATR%) above ~3% is treated as elevated risk.
Bear Case
- MACD histogram is negative (-0.125) — bearish momentum.
- Bearish candlestick pattern(s) detected: Three Black Crows.
- Risk/reward is unfavorable: 8.7% downside vs 0.4% upside.
AI Investment Committee
Committee Consensus
As of July 11, 2026
Overall Committee Score
59/100
Agreement
50%
Analysts
6
Conviction
Contested
Value Analyst
neutral
48
/ 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 17.9% shows genuine earnings power backing the valuation
− P/E of 34.1 is moderate-to-rich
Growth Analyst
neutral
44
/ 100 · High confidence
Moderate growth -- present but not remarkable
+ 4 consecutive earnings beats -- consistent execution
− EPS declining -48.3% YoY despite any revenue growth
Technical Analyst
neutral
57
/ 100 · High confidence
Mixed or range-bound price action
+ Price structure making higher highs and higher lows
− MACD histogram negative -- bearish momentum
Risk Analyst
bearish
35
/ 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− Bollinger bandwidth of 17.9% signals elevated volatility
Macro Analyst
bullish
70
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst
bullish
62
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
Portfolio Manager
bullish
75
/ 100 · Low confidence
The existing book is healthy enough that position-sizing here is a matter of stock selection, not portfolio constraints
+ Portfolio position concentration is currently healthy
Technical Analysis
RSI (14)
45.9
Neutral
MACD Histogram
-0.125
Bearish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Mixed
Support
$112.75
Resistance
$123.97
Bollinger %B
0.54
Inside Bands
Price vs Moving Averages
EMA 9
$125.45
Below
EMA 21
$123.38
Above
EMA 50
$120.20
Above
EMA 200
$110.51
Above
Fundamental Analysis
Valuation
34
Growth
36
Profitability
82
Financial Health
70
Valuation
P/E Ratio
34.7×
P/B Ratio
4.97×
PEG Ratio
—
Dividend Yield
2.72%
52W High
$130.29
52W Low
$76.66
Quality & Growth
ROE
1793.0%
ROA
697.0%
Gross Margin
7807.0%
Operating Margin
1818.0%
Revenue Growth YoY
+289.0%
Debt / Equity
0.94
AI Fundamental Assessment
P/E ratio of 34.7 (rich relative to a 15-40x range); Price-to-book of 5.0x; Revenue growth (YoY) of 2.9%; EPS growth (YoY) of -48.3%; Return on equity of 17.9%; Return on assets of 7.0%; Net margin of 13.6%; Gross margin of 78.1%; Current ratio of 1.54 (healthy short-term liquidity); Debt-to-equity of 0.94; Most recent quarter beat estimates by 16.0%; 4 consecutive earnings beats; EPS growth decelerating (-22.0% -> -161.2% QoQ); Analyst estimates falling over recent quarters
Key Risks
- MACD histogram is negative (-0.125) — bearish momentum.
- Bearish candlestick pattern(s) detected: Three Black Crows.
- Risk/reward is unfavorable: 8.7% downside vs 0.4% upside.
This risk summary is generated from quantitative data signals, not qualitative opinion. All investors should conduct their own due diligence. This is not financial advice.
Get the Full MRK Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Mobile